Top Stories

PLIVA V. MENSING–Supreme Court Determines Failure to Warn Claims Against Generic Pharmaceutical Manufacturers are Preempted Under Ferderal Law

On June 23, 2011, the United States Supreme Court issued its decision in Pliva, Inc. v. Mensing, No. 09-993, 564 U.S. ___ (2011), which effectively eliminates claims against generic pharmaceutical manufacturers for failing to provide adequate warnings required by state law.  In Mensing, the plaintiffs alleged that the manufacturers of generic metoclopramide, a drug used […] More >

Defense Verdict for Johnson & Johnson in Antibiotic Case

The Nilan Johnson Lewis team, led by shareholder Tracy J. Van Steenburgh, helped secure a defense verdict in Minnesota federal court on June 17, 2011, for Defendants Ortho-McNeil-Janssen Pharmaceuticals, Inc. and Johnson & Johnson in a case involving the companies’ antibiotic Levaquin®.  Plaintiff Calvin Christensen said he ruptured his right Achilles tendon after taking Levaquin […] More >

Investors Now Can Choose An All-Public Arbitration Panel

The Securities and Exchange Commission (SEC) recently approved a proposed rule of the Financial Industry Regulatory Authority (FINRA) that provides investors the option of choosing all public arbitrators in cases with three arbitrators.  The new rule became effective February 1, 2011. FINRA rules require a three-arbitrator panel in customer disputes with claims over $100,000.  In […] More >

Nilan Johnson Lewis Office Earns LEED Certification

Just over a year after relocating to its new office in One Financial Plaza, Nilan Johnson Lewis has become LEED certified, earning third-party recognition for its attainment of the “highest green building and neighborhood performance measures,” by the Green Building Certification Institute.  Kim Ess, Chief Operating Officer for Nilan Johnson Lewis, said: “The space is such a […] More >